Seamless Therapeutics Enters $1.12 Billion Global Research Collaboration with Eli Lilly to Develop Therapeutics for Hearing Loss
Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and Company to develop and...
